Literature for TMI-1
(Topics flags: A Assay, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Moss,M.L. and Rasmussen,F.H.
Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening
Anal Biochem366, 144-148. PubMed Europe PubMed DOI A I -
[YEAR:23-1-2004]Zhang,Y., Xu,J., Levin,J., Hegen,M., Li,G., Robertshaw,H., Brennan,F., Cummons,T., Clarke,D., Vansell,N., Nickerson-Nutter,C., Barone,D., Mohler,K., Black,R., Skotnicki,J., Gibbons,J., Feldmann,M., Frost,P., Larsen,G. and Lin,L.L.
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpho linecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis
J Pharmacol Exp Ther309, 348-355. PubMed Europe PubMed DOI I
2007
2004
